Discovery of highly potent and selective KRASG12C degraders by VHL-recruiting PROTACs for the treatment of tumors with KRASG12C-Mutation.
Yang N, Fan Z, Sun S, Hu X, Mao Y, Jia C, Cai X, Xu T, Li B, Li Y, Han L, Wei T, Qian X, Qin W, Li P, Zheng Z, Li S.
Yang N, et al. Among authors: qin w.
Eur J Med Chem. 2023 Dec 5;261:115857. doi: 10.1016/j.ejmech.2023.115857. Epub 2023 Oct 13.
Eur J Med Chem. 2023.
PMID: 37852032